Annette Pflugfelder - Concepedia

Author

Annette Pflugfelder

University of Tübingen ORCID

Also Known As

A Pflugfelder, A. Pflugfelder, Annette Dorothee Pflugfelder, Annette Pflugfelder, Pflugfelder, Annette Dorothee

Publications

2.2K

Citations

H-Index

Concepts

All Affiliations

University of Tübingen James Cook University Heidelberg University STZ eyetrial German Cancer Research Center

About

Annette Pflugfelder is an author at University of Tübingen specializing in medicine, oncology, and tumor microenvironment.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	678
2	Immunology	3	3	529
3	Health Sciences	2	2	78
4	Engineering	1	1	100
5	Diagnostic Sciences	1	1	24

Annette Pflugfelder

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Direct Injection of Protamine-protected mRNA: Results of a Phase 1/2 Vaccination Trial in Metastatic Melanoma Patients Benjamin Weide, Steve Pascolo, Birgit Scheel, Journal of Immunotherapy Vaccination TrialImmunologyImmunologic MechanismImmunotherapeuticsDirect Injection	2009	375
A Dose-Escalation and Signal-Generating Study of the Immunocytokine L19-IL2 in Combination with Dacarbazine for the Therapy of Patients with Metastatic Melanoma Thomas Eigentler, Benjamin Weide, Filippo de Braud, Clinical Cancer Research	2011	149
High response rate after intratumoral treatment with interleukin‐2 Benjamin Weide, Evelyna Derhovanessian, Annette Pflugfelder, Cancer	2010	139
Serum markers lactate dehydrogenase and S100B predict independently disease outcome in melanoma patients with distant metastasis Benjamin Weide, Margrit Elsässer, Petra Büttner, British Journal of Cancer	2012	137
Functional T Cells Targeting NY-ESO-1 or Melan-A Are Predictive for Survival of Patients With Distant Melanoma Metastasis Benjamin Weide, Henning Zelba, Evelyna Derhovanessian, Journal of Clinical Oncology	2012	116
The Prognostic and Predictive Value of Melanoma-related MicroRNAs Using Tissue and Serum: A MicroRNA Expression Analysis Mitchell Stark, Kerenaftali Klein, Benjamin Weide, EBioMedicine Melanoma TissuesEngineeringImmunologyPathologyMelanoma Progression	2015	100
Intralesional Treatment of Stage III Metastatic Melanoma Patients with L19–IL2 Results in Sustained Clinical and Systemic Immunologic Responses Benjamin Weide, Thomas Eigentler, Annette Pflugfelder, Cancer Immunology Research	2014	96
Open label randomized study comparing 3 months vs. 6 months treatment of actinic keratoses with 3% diclofenac in 2.5% hyaluronic acid gel: a trial of the German Dermatologic Cooperative Oncology Group Annette Pflugfelder, A. Welter, Ulrike Leiter, Journal of the European Academy of Dermatology and Venereology	2011	55
Survival after intratumoral interleukin-2 treatment of 72 melanoma patients and response upon the first chemotherapy during follow-up Benjamin Weide, Thomas Eigentler, Annette Pflugfelder, Cancer Immunology Immunotherapy Cancer ImmunosurveillanceMedicineMelanomaImmunologyImmune Checkpoint Inhibitor	2010	54
Survival According to BRAF-V600 Tumor Mutations – An Analysis of 437 Patients with Primary Melanoma Diana Meckbach, Jürgen Bauer, Annette Pflugfelder, PLoS ONE Skin CancerTumor HeterogeneityMedicineMelanomaPathology	2014	54

Page 1